Creative Medical Technology Holdings Announces MyeloCelz™ The Company’s Second Regenerative Immunotherapy Product
- Tuesday, July 20, 2021, 7:05
- Finance
- Add a comment
PHOENIX, July 20, 2021 /PRNewswire/ — (OTC – CELZ) Creative Medical Technology Holdings Inc. announced today the launching of its second Regenerative Immunology product, MyeloCelz™. In contrast to the Company’s ImmCelz™ product, which utilizes primarily T cells and B cells to induce…
About the Author
adminasapcorp has written 41794 stories on this site.